AU2001271252A1 - Methods for helper-dependent adenoviral vector production - Google Patents

Methods for helper-dependent adenoviral vector production

Info

Publication number
AU2001271252A1
AU2001271252A1 AU2001271252A AU7125201A AU2001271252A1 AU 2001271252 A1 AU2001271252 A1 AU 2001271252A1 AU 2001271252 A AU2001271252 A AU 2001271252A AU 7125201 A AU7125201 A AU 7125201A AU 2001271252 A1 AU2001271252 A1 AU 2001271252A1
Authority
AU
Australia
Prior art keywords
helper
methods
adenoviral vector
vector production
dependent adenoviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271252A
Inventor
Donna Armentano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2001271252A1 publication Critical patent/AU2001271252A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001271252A 2000-06-29 2001-05-16 Methods for helper-dependent adenoviral vector production Abandoned AU2001271252A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21504700P 2000-06-29 2000-06-29
US60/215,047 2000-06-29
US25974801P 2001-01-04 2001-01-04
US60/259,748 2001-01-04
PCT/US2001/015784 WO2002002788A2 (en) 2000-06-29 2001-05-16 Methods for helper-dependent adenoviral vector production

Publications (1)

Publication Number Publication Date
AU2001271252A1 true AU2001271252A1 (en) 2002-01-14

Family

ID=26909633

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271252A Abandoned AU2001271252A1 (en) 2000-06-29 2001-05-16 Methods for helper-dependent adenoviral vector production

Country Status (3)

Country Link
US (1) US20020081707A1 (en)
AU (1) AU2001271252A1 (en)
WO (1) WO2002002788A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69534166T2 (en) * 1994-10-28 2006-03-09 Trustees Of The University Of Pennsylvania RECOMBINANT ADENOVIRUS AND METHODS OF USE THEREOF
JP2002538758A (en) * 1998-02-17 2002-11-19 ジェンザイム・コーポレイション Method for producing pseudo adenovirus vector
DE69924808D1 (en) * 1998-05-27 2005-05-25 Transgene Sa CHIMERIC ADENOVIRAL VECTORS
EP1151091A4 (en) * 1999-02-04 2002-09-04 Merck & Co Inc Improved helper dependent vector system for gene therapy
US6867022B1 (en) * 2000-01-21 2005-03-15 Regents Of The University Of Michigan Replication deficient adenovirus vectors and methods of making and using them

Also Published As

Publication number Publication date
WO2002002788A3 (en) 2003-01-03
US20020081707A1 (en) 2002-06-27
WO2002002788A2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AUPR464601A0 (en) Shapes vector
AU2001249395A1 (en) Isolated instructions for isolated execution
AU2003295502A1 (en) Adenoviral vector vaccine
AU3404901A (en) Constructive nanolithography
AU2001282481A1 (en) Articulated structure
AU2001232054A1 (en) Vector
AU2001276549A1 (en) Transglutaminase for inhibiting angiogenesis
AU2002360353A1 (en) Receptor-targeted adenoviral vectors
AU2002356180A1 (en) Methods for inhibiting angiogenesis
AU3274401A (en) Compositions and methods for efficient aav vector production
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2002252801A1 (en) Peptides derived from colostrinin
AU2333001A (en) Double selection vector
AU2001220281A1 (en) Rollerboard for road-skiing
AU2002337892A1 (en) Vectors for expressing multiple transgenes
AU5250100A (en) Vector for expressing two foreign genes
AU2002218440A1 (en) New process
AU2001288839A1 (en) Self-rearranging dna vectors
AU2002216268A1 (en) Elongase promoters
AU2001271252A1 (en) Methods for helper-dependent adenoviral vector production
AU4672401A (en) Vectors
AU2001267769A1 (en) Process
AU2002256274A1 (en) Minimal adenoviral vectors for immunization
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
AUPQ821000A0 (en) Rack yoke